Eton Pharmaceuticals, Inc. · NASDAQ:ETON
Riedel Norbert G exercised options for 32,155 Eton Pharmaceuticals, Inc. shares (Form 4)
Traded Apr 21, 2026 · Filed Apr 22, 2026
On Apr 21, 2026, Riedel Norbert G (Director) exercised options for 32,155 Eton Pharmaceuticals, Inc. shares at an average US$8.10 for US$261K, leaving 67,155 shares. Filed Apr 22, 2026 (Form 4).
- Options exercised
- 32,155 shares
- Price
- US$8.10 average (US$7.31 to US$8.61)
- Value
- US$261K
- Holding after
- 67,155 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 21, 2026 | Common Stock | Option exercise | 12,500 | US$7.31 | 47,500 | Direct |
| Apr 21, 2026 | Common Stock | Option exercise | 19,655 | US$8.61 | 67,155 | Direct |